1. Introduction
A developing immune system, high respiration rates, and an energetic physical state make children more vulnerable to diseases such as fever, pain, and rhinitis. Elevated body temperature is triggered by a complex interplay of internal factors related to inflammation, infection, or malignancies and external factors like pathogens and toxins [1,2]. Fever, discomfort, and uneasiness usually cripple activity in children. Generally, as the first option, parents administer antipyretics and analgesics before seeking medical intervention to lessen the harmful consequences of fever [3]. A study conducted in Saudi Arabia has revealed that 84.5% of parents administer paracetamol to manage fever in their children [4]. An observational study by Kamel et al. in Jeddah, Saudi Arabia, evaluated parental knowledge and practice using ibuprofen and paracetamol. This study highlighted a lack of parental awareness of the correct dose and frequency of administration of paracetamol [5]. Furthermore, another study indicated that 93.3% of parents prefer to self-medicate their child with paracetamol to avoid spending time in pediatric clinics [6]. In addition, the recent COVID-19 pandemic has increased parental concerns and anxiety when the child develops a fever. This heightened concern is often driven by the thought that the fever could indicate a COVID-19 infection [7]. A post-pandemic study has revealed that parents are more inclined to attribute fever to COVID-19 than other symptoms like cough [8]. As a result, there has been a marked increase in the utilization of paracetamol due to fear [9]. Additionally, numerous guidelines and recommendations were put forth during the pandemic regarding antipyretic medications [10,11,12], bolstering confidence in their utilization. Furthermore, the reliance on paracetamol could be higher, as it is an easily accessible over-the-counter medication [13]. Thus, treating illnesses in children at home is often performed with the best intentions, but it can sometimes have adverse consequences.
Paracetamol, an analgesic and antipyretic, inhibits the formation of prostaglandins. The analgesic effect is also attributed to N-acylphenolamine, a paracetamol metabolite that activates the cannabinoid 1 and transient receptor potential vanilloid 1 [14].
Paracetamol is proven to be safe if administered in recommended doses. However, irrational use of paracetamol has been linked to adverse outcomes in various age groups and geographic regions [15,16]. Moreover, higher doses of paracetamol can cause hepatic and renal failure due to the formation of a toxic metabolite, N-acetyl-p-benzoquinoneimine, which depletes glutathione reserves, causing damage to hepatic and renal macromolecules [17,18]. Research conducted with caregivers at the Faisal Specialist Hospital and Research Centre in Saudi Arabia has revealed that 30% of the parents administer paracetamol in supratherapeutic doses to their sick children [16]. Intentional or accidental overdosing cannot be ruled out if the doses are not spaced adequately, adult formulations are used, and two or more medications containing paracetamol are given together, potentiating the risk of overdosage. Paracetamol-related poisoning is reported worldwide, with emergency departments in European countries such as Spain and Norway recording poisoning ranging from 4.5% to 12% [19,20]. In Saudi Arabia, almost 30% of cases of paracetamol poisoning have been reported [21], while 40–44% of cases have been noted in the United Kingdom [22]. The poison control center in the United States of America received 80,000 cases related to the use of paracetamol in 2021 alone [23]. A single supratherapeutic dose of paracetamol could cause acute poisoning, and repeated supratherapeutic doses can cause chronic poisoning. A 150 mg/kg or 100 mg/kg dose with other precipitating factors may cause acute poisoning in children [24].
We perceive that there could be potential knowledge and practice gaps which could affect the proper dosing, duration, and frequency of administration of paracetamol. Additionally, variations in parental knowledge, exposure, approach, and techniques can alter how an afflicted child is handled, potentially increasing the risk of toxicity. Moreover, due to the widespread availability and likely increased use of paracetamol post-pandemic, it is crucial to assess caregiver behaviors at periodic intervals. Therefore, this study aimed to assess perceptions and practices of caregivers in Saudi Arabia regarding the use of paracetamol for childhood illnesses.
2. Methods
2.1. Study Design
A study with a cross-sectional design was carried out, focusing on parents or guardians, collectively referred to as caregivers.
2.2. Ethics Approval
This study was approved by the Institutional Review Board, College of Pharmacy, bearing the number Rec-4/10/656 dated 19 May 2023.
2.3. Study Setting
Caregivers visiting primary healthcare centers and the outpatient pediatric department of tertiary care hospitals in the Jazan region, a part of Southwestern Saudi Arabia, were requested to participate in the study. The Jazan region has 170 primary healthcare centers (PHCs) and tertiary care hospitals. For a population of 10,000, the rate of PHCs is 1.08 [25]. PHCs were randomly selected from the compiled list using the table of random numbers.
2.4. Participants
We included caregivers seeking medical intervention for the child aged between 1 and 12 years willing to participate and assured them of the confidentiality of information. The inclusion criteria set was paracetamol administration by the caregiver before seeking medical attention. We excluded caregivers with a child under one year if paracetamol was not administered to their child or the child was treated with paracetamol for only one day. Data from caregivers were gathered using a convenience sampling approach between May 2023 and December 2023.
2.5. Sample Size
The estimation of the sample size required for assessing the prevalence of paracetamol usage as a remedy for children under twelve in the Jazan region, with a population of 1.56 million, was conducted using a statistical approach to ensure accuracy and reliability of the findings. Given the assumption that 50% of caregivers administer paracetamol to children under twelve, this study aimed for a 95% confidence level, with a margin of error set at 5% to delineate the acceptable variability in results. Utilizing the Raosoft sample size calculator, it was determined that a sample size of 385 caregivers was necessary to meet these parameters. To compensate for potential non-response, the sample size was adjusted to 405. This size is sufficient to accurately reflect the usage patterns of paracetamol within the specified confidence level and margin of error, thus providing a reliable basis for understanding the prevalence of its use in the target population.
2.6. Data Collection Tool
Following a thorough examination of the existing literature on the administration of paracetamol to children [26,27], a questionnaire was developed in English and scrutinized by two practicing pharmacists. The survey questionnaire was translated into Arabic to make it suitable for use among the caregivers. The questionnaire underwent a forward and back translation process between Arabic and English, facilitated by a linguist. The original questionnaire and its translated version were carefully examined to identify discrepancies. Next, an informal evaluation was conducted involving 20 caregivers who visited the same hospital in the early days of May. This review aimed to ensure that the questions were understandable, pertinent, and suitable based on the objectives of this survey. Additionally, individuals responsible for administering the questionnaire received specialized training to reduce interpersonal variations.
The survey questionnaire covered a range of essential aspects, including demographic information about caregivers (such as age, gender, location, and education), the child’s age, and inquiries about caregivers’ practices related to administering paracetamol, including questions about dosage, frequency, and duration of use. It also delved into topics concerning the safe usage of paracetamol. Additionally, the questionnaire explored the reasons caregivers brought the child to the hospital and identified the sources of information they relied on for administering paracetamol.
2.7. Data Processing and Analysis
The data were analyzed using SPSS Statistics for Windows, IBM, Version 23.0 (Armonk, NY, USA). Frequency measures are denoted in absolute terms along with the percentages. The relationship between the variables was analyzed using either the Chi-square test or Fisher’s exact test, depending on which was more suitable for the data. Multivariate logistic regression was performed on selected dependent variables with dichotomous options after adjusting for age and caregiver type. The level of statistical significance was set at p < 0.05.
3. Results
3.1. Demographic Information
Three hundred and seventy-three caregivers responded to our survey, resulting in a response rate of 88.38%. Most respondents were parents, with only about 10% of relatives or nannies. The caregivers predominantly ranged in age from 31 to 40 years, with 39.1% having secondary or higher education. Caregivers were equally split between urban and rural residents, and most were Saudis. Children aged 7–9 years and 10–12 years were the most represented age groups of the respondents (Figure 1).
3.2. General Perception of Caregivers about Paracetamol
Although most caregivers did not administer paracetamol in conjunction with other medications, a small number did. Of those, only 9.9% checked the contents on the label. Almost one-half of the caregivers admitted that the use of paracetamol increased post-pandemic, and an equal proportion were uncertain about whether paracetamol could be used for all pediatric health issues. Most caregivers predominately used home-stored medicines, while a few opted for tepid sponging and hydration. Paracetamol was predominately used to manage fever (50.1%), followed by headaches, vomiting, and fever associated with COVID-19 vaccination; however, its use to manage cough was comparatively low. Over one-half of the caregivers sourced paracetamol from their home supplies, with the remainder obtaining it from physicians and pharmacies. Caregivers ascertained the dose based on their personal experience and sought advice from relatives and consulting physicians. However, reading the label was a less favored option. Almost one-third of the caregivers did not receive formal counselling on the use of paracetamol (Table 1).
3.3. Caregiver Perceptions on the Safe Use of Paracetamol
A minority of the caregivers affirmed that paracetamol is safe. Educational level was significantly associated with the assertion that paracetamol is safe (χ2 = 8.44 (3), p = 0.037). Further, the logistic regression model demonstrated that caregivers with education up to the primary level were 2.98 times more likely to believe that paracetamol is safe (AOR = 2.98 (CI:1.3–6.73), p = 0.009) compared to those with secondary and higher education (Table 2).
3.4. Caregiver Practices Regarding the Use of Paracetamol
Most caregivers (60.6%) administered paracetamol for three days, while 19% extended administration beyond five days. Over one-third of caregivers aged between 31 and 40 years administered paracetamol for over five days. A significant association was found between educational level and the decision regarding the duration of treatment (χ2 = 21.58 (4), p < 0.001). Over a 24 h period, 64.1% of caregivers administered paracetamol every 3 h, 16.3% every 5 h, and 19.6% every 6 h. Frequency of administration over 24 h was significantly associated with education (χ2 = 17.77 (4), p = 0.001) but not with age and caretaker type. Approximately half of the caregivers gave paracetamol based on the severity of the fever, and this was more prevalent among caregivers aged between 31 and 40 years, but the association was not statistically significant. A statistically significant association was found between caregivers’ educational level (χ2 = 30.70 (4), p < 0.001) and selecting paracetamol dose based on age, body weight, and severity of fever (Table 3).
3.5. Practices in Reviewing Critical Safety Information
Most caregivers referred to the directions on the label, while approximately half noticed the warning. A significant association was found between caregiver type and their attention to label warnings (χ2 = 7.51 (2), p < 0.023). Among caregivers aged 31 to 40, 48.3% checked the directions on the label and 28.7% overlooked it; however, no significant relationship between age and safe practices was observed. About 32% of the caregivers with secondary or higher education followed the label directions, and a statistically significant association was found between education and checking directions on the label (Fisher exact = 15.98, p < 0.001) and warnings on the label (χ2 = 61.60 (2), p < 0.001). The logistic regression model revealed that caregivers with only primary education or less (adjusted odds ratio (AOR) (95% CI): 0.11 (0.05–0.25), p < 0.001) and those with intermediate education (AOR (95% CI): 0.19 (0.11–0.31), p < 0.001) were significantly less likely to check warnings compared with those with secondary and higher education (Table 4).
3.6. Caregivers’ Practice of Checking the Expiry Date
Approximately 73% of the caregivers with intermediate to higher education and 46.1% aged between 31 and 40 years checked the expiration date. A statistically significant association was found between education and checking the expiry date (χ2 = 81.34 (2), p < 0.001). Caregivers with primary education or less were significantly less likely to check expiry date (AOR: 0.063 (0.027–0.14), p < 0.001) compared to those with secondary and higher education (Table 5).
3.7. Reasons for Seeking Assistance
Figure 2 outlines the reasons caregivers sought help, with failed home treatment (35.2%) and vomiting (28.7%) being the most common, while a few sought assistance when the child changed their eating habits and was weak.
4. Discussion
This study identified some misconceptions among caregivers initiating treatment with paracetamol.
Nearly sixty percent of the caregivers in our study were in the age group between 31 and 40 years, and 22% fell within the age range of 18 and 30 years. These findings align with those of Obu et al., who reported that 90.3% of caregivers were aged between 18 and 57 years [28].
The administration of paracetamol in pediatric populations is a ubiquitous practice, with caregivers frequently utilizing it for fever management [29]. While paracetamol is considered to be safe when used in recommended doses [27,30], tolerability changes as the dose increases [27], thus inundating the body’s capacity to process it safely. In our setting, caregivers cited various reasons for administering paracetamol in children, with around half acknowledging its use for fever reduction, and this finding is consistent with previous studies. For instance, a study by De Bont et al. in the Netherlands found that paracetamol use was the highest in children aged 5 to 12 years, and the use was also seen during follow-up [31]. Similarly, a study conducted in Rome has reflected that their caregivers have given 72% of children paracetamol for fever management [32]. Furthermore, a study performed in a Northern Nigerian population revealed that 68.3% of the caregivers administered paracetamol to children for fever reduction [33]. This percentage is higher than that reported in our study, highlighting regional disparities in caregiver practices and paracetamol usage patterns.
Moreover, the use of paracetamol has increased post-pandemic, possibly due to fear and anxiety. Mattiuzzi and Lipp, in an infodemiological analysis, revealed that the use of paracetamol substantially increased compared with the pre-COVID period [34].
When respondents were asked if “paracetamol can be used for all health issues in children”, we expected the majority to respond in the negative; however, nearly one-half were unsure, and 23.1% agreed that it could be used. In line with our findings, an earlier study in Malaysia has also reported that paracetamol has been used for unintended reasons [35]. In contrast to what we observed, another study conducted in Jeddah, Saudi Arabia, reported that a little less than three-fourths of the caregivers felt that paracetamol should not be given [5]. The difference in perception could be attributed to the limited health literacy or inadequate counselling by healthcare professionals. Unfortunately, it was also observed that some caregivers had used paracetamol for vomiting and diarrhea and to manage fever/irritability associated with COVID-19 vaccination.
Approximately two-thirds of the caregivers stated that paracetamol is a safe medication; among whom 34.3% are mothers. The results of our study correspond to the findings of a Malaysian study, where 69.1% of consumers held similar views [26]. Moreover, we also found some caregivers administering other medications concurrently with paracetamol. This is not an isolated case, as a study among caregivers in Australia also reported that 45.8% gave dual therapy to their children [36]. Furthermore, caregivers with primary education and, to an extent, some with intermediate education were more likely to consider paracetamol as safe. This raises concerns about potential risks associated with this misunderstanding.
The decision about determining the dose, duration, and frequency of administration of paracetamol yielded favorable as well as concerning results. The correct dose of paracetamol should be based on body weight and not on the age or severity of the condition [37]. Unfortunately, over two-fifths of the parents determined the dose based on the severity of the fever. The study by Kamel et al. in Jeddah, Saudi Arabia, reported a similar trend, with caregivers administering paracetamol based on the severity of the condition; however, the proportion of use was lower than in our respondents [5]. In our survey, more than half of the parents administered paracetamol at inappropriate intervals, specifically every three hours, and a minority extended treatment beyond five days. In contrast, a study conducted in Palestine showed that 61.6% of caregivers administered paracetamol over 4–6 h, but 21.3% administered it every two hours [27]. The deviation in dosing decisions might be attributed to caregivers considering symptom severity a crucial factor. Hence, while comparing our results to the existing literature, we found that irregular dosing frequency and duration are widespread and not confined to a specific region. Also, the educational background of caregivers could impact informed choices regarding the appropriate use of paracetamol.
A little less than one-half of the caregivers had used their personal experience to decide the dose and frequency of administration. An Australian study revealed a similar trend despite respondents having high health literacy [38]. Interestingly, nearly thirty percent of the respondents in our study sought advice from family/friends, a response rate higher than that reported in a previous study in Saudi Arabia, where only 12.6% consulted family and 1.8% consulted friends [39]. The difference in information-seeking behavior could plausibly be attributed to the level of education in their sample population, which had 58.4% graduates, as opposed to 39% with secondary education and above in our sample.
When caregivers were asked about self-care measures for sick children, most opted for home-stored medications, with alternative methods such as tepid sponging and fluid replenishment utilized less. However, the latter helps to reduce the risk of dehydration. The preference for paracetamol among caregivers can be attributed to its over-the-counter availability, frequent physician recommendations, and caregiver familiarity with the medication.
The level of education among the caregivers significantly influences their tendency to check label warnings. Caregivers with elementary education and less and intermediate education were significant predictors, as they were less likely to check the warning on the label relative to caregivers with secondary and higher education. This coincides with the results reported in a study in Malaysia, indicating that caregivers with lower education did not refer to label information [35]. In addition, we found caregiver type significantly associated with their ability to check the warning on the label. Further, caregivers with education up to the primary level were much less likely to check the expiry date than caregivers with higher education. A study conducted on university students in Pakistan revealed that a mere 16.6% of them read the information provided on the label, thus suggesting that even among the educated, there exists a gap in reading medication labels [40]. Expired medications lose their potency and degrade into harmful chemicals, thus could cause an unintentional risk in children.
We identified caregivers seeking professional medical help only when home treatment failed. The response resonated with another study, where the use of unprescribed medicines caused a delay in seeking care [41]. On the other hand, some caregivers sought medical care when their child was frail and anorectic, suggesting a compromised nutritional status. Administration of paracetamol to a nutritionally compromised child can increase the risk of liver toxicity, as poor nutrition can diminish antioxidants such as glutathione [42,43,44].
The widespread misuse of paracetamol among caregivers, often based on the severity of fever rather than proper dosing guidelines, can lead to under or overdosing. Underdosing can prolong the illness, while more frequent and higher doses can result in hepatic complications. The misconception that “paracetamol is fit for all” may delay necessary professional medical consultation, worsening the health condition of the child. This misuse of over-the-counter medications like paracetamol can become a considerable public health challenge. Furthermore, the associated rise in emergency department visits and hospitalization can burden healthcare systems substantially. Healthcare professionals can provide medication counselling to mitigate these risks, especially for caregivers with limited health literacy. Secondly, stricter regulations on the sale and advertising of over-the-counter medications like paracetamol could help in preventing stockpiling and misuse. Such measures would collectively improve patient safety and reduce the load on an already burdened healthcare system.
This study has some limitations. Firstly, as it was a self-report, there could be a possibility of under-reporting the over-use of paracetamol, which could skew the results. Further, the number of caregivers with lower education was not proportional to the rest of the participants, which could impact generalizability. Despite these limitations, this study successfully identified several misconceptions about the use of paracetamol in children, which can help in designing educational interventions.
5. Conclusions
In conclusion, the observed increase in paracetamol use post-COVID-19 signifies a shift in self-care practices among caregivers. Misconceptions among caregivers led them to use paracetamol for various health issues in children. This study highlights that many caregivers perceive paracetamol as inherently safe and base their dosing decisions on the severity of symptoms rather than body weight. Relying on personal experience rather than professional guidance has led to inappropriate dosing frequencies and durations, which can adversely impact pediatric health. Moreover, caregivers with only primary or intermediate education were less likely to consult or correctly interpret medication labels. These findings reflect prevalent misconceptions about paracetamol among caregivers, necessitating educational and counselling initiatives to promote the rational and safe use of paracetamol in children.
D.B., O.J.F.B. and S.S.A. played key roles in the conception, design, data collection, analysis, and data interpretation aspects of the study. S.S.A. and O.J.F.B. initially drafted the manuscript, while D.B. was responsible for subsequent revisions. All authors made significant contributions to the article and gave their approval for the version that was submitted. All authors have read and agreed to the published version of the manuscript.
This research study received ethical approval from the Ethics Review Committee, College of Pharmacy, Jazan University, Saudi Arabia, bearing the number Rec-4/10/656, dated 19 May 2023.
Informed consent was obtained from all subjects involved in the study.
This will be provided upon reasonable request.
The authors declare no conflicts of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Enlarge this image.Figure 1. Demographic characteristics of the caregivers and the children treated with paracetamol.
Perceptions of caregivers on the use of paracetamol in children.
| Variable | Response | Variable | Response |
|---|---|---|---|
| Can paracetamol be used for all | Reasons for giving paracetamol | ||
| Yes | 86 (23.1) | Fever | 187 (50.1) |
| No | 102 (27.3) | Generalized body pain/earache/headache | 61 (16.4) |
| Not sure | 184 (49.3) | Diarrhea/vomiting | 71 (19) |
| Has your use of paracetamol | Irritability due to COVID-19 vaccination | 36 (9.7) | |
| Yes | 187 (50.1) | Cough | 18 (4.8) |
| No | 185 (49.6) | Source of paracetamol | |
| Given other medication along | Home-stored | 195 (52.3) | |
| Yes | 59 (15.8) | Pharmacy | 64 (17.2) |
| No | 314 (84.2) | Doctor | 114 (30.6) |
| If yes, did you check the contents | Determination of dose | ||
| Yes | 37 (9.9) | Personal experience | 164 (44) |
| No | 22 (5.9) | Relatives/friends | 126 (29.9) |
| Type of selfcare given to | Physician | 97 (26) | |
| Home-stored medicines | 267 (71.6) | Suggestions from healthcare professionals | 62 (16.6) |
| Plenty of fluids | 56 (15) | Directions on label | 50 (13.4) |
| Tepid sponging | 50 (13.4) | Received counselling | |
| Suggestions from healthcare professionals | 62 (16.6) | Yes | 253 (68) |
| No | 119 (32) | ||
Assessment of the association between caregivers’ perception that paracetamol is safe against demographic variables.
| Independent Variable | Dependent Variable | χ2 (df) | p-Value | AOR & 95% CI | p-Value | |
|---|---|---|---|---|---|---|
| Paracetamol Is Safe | ||||||
| Yes (%) | No (%) | |||||
| Caregiver | 0.417 (2) | 0.813 | ||||
| Mother | 128 (34.3) | 74 (19.8) | 1 | |||
| Father | 76 (20.4) | 51 (13.7) | 0.66 | 0.28 | ||
| Nanny/relatives | 27 (7.2) | 17 (4.6) | 0.89 | 0.77 | ||
| Age (Years) | 1.72 (2) | 0.72 | ||||
| 18–30 | 53 (14.2) | 29 (7.8) | 0.94 | 0.86 | ||
| 31–40 | 131 (35.1) | 90 (24.1) | 0.74 | 0.31 | ||
| Above 40 | 47 (12.6) | 23 (6.2) | 1 | |||
| Education | 8.44 (3) | 0.037 * | ||||
| Up to primary education | 20 (5.4) | 7 (1.9) | 2.98 | 0.009 * | ||
| Intermediate | 104 (27.9) | 68 (18.2) | 1.20 | 0.42 | ||
| Secondary and higher | 61 (16.4) | 51 (13.7) | 1 | |||
| Domicile | 0.20 (1) | 0.65 | ||||
| Urban | 121 (32.4) | 71 (19) | 1 | |||
| Rural | 110 (29.5) | 71 (19) | 1.18 | 0.44 | ||
| Nationality | 0.87 (1) | 0.34 | ||||
| Saudi | 140 (37.5) | 79 (21.2) | 1 | |||
| Non-Saudi | 91 (24.4) | 63 (16.9) | 1.09 | 0.67 | ||
* p < 0.05 considered statistically significant.
Assessment of the caregiver practices regarding the administration of paracetamol and its association with demographic variables.
| Duration of Treatment (Days) | χ2 (df), p-Value | You Give Paracetamol Based on | χ2 (df), p-Value | Number of Times Paracetamol Is Given in 24 h. N (%) | χ2 (df), p-Value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 5 | >5 | Age | Body Weight | Severity of Fever | Every 3 h | Every 5 h | Every 6 h | ||||
| Caregiver | 1.07 (4), | 8.74 (4), p = 0.068 | 6.59 (4), p = 0.15 | |||||||||
| Mother | 125 (33.5) | 38 (10.2) | 39 (10.5) | 76 (20.4) | 30 (8) | 96 (25.7) | 128 (34.3) | 37 (9.9) | 37 (9.9) | |||
| Father | 81 (21.7) | 28 (7.5) | 24 (6.4) | 34 (9.1) | 32 (8.6) | 65 (18) | 92 (24.7) | 15 (4) | 26 (7) | |||
| Relatives/Nanny | 20 (5.4) | 10 (2.7) | 8 (2.1) | 16 (4.3) | 7 (1.9) | 15 (4) | 19 (5.1) | 9 (2.4) | 10 (2.7) | |||
| Age (Years) | 7.82 (6), p = 0.25 | 1.25 (4), p = 0.86 | 4.13 (4), | |||||||||
| 18–30 | 50 (13.4) | 17 (4.6) | 15 (4) | 28 (7.5) | 17 (4.6) | 37 (9.9) | 54 (14.5) | 17 (4.6) | 11 (2.9) | |||
| 31–40 | 137 (36.7) | 44 (11.8) | 40 (10.7) | 74 (19.8) | 42 (11.3) | 105 (28.2) | 142 (38.1) | 31 (8.3) | 48 (12.9) | |||
| Above 40 | 39 (10.5) | 15 (4) | 16 (4.3) | 24 (6.4) | 10 (2.7) | 36 (9.7) | 43 (11.5) | 13 (3.5) | 14 (3.8) | |||
| Education | 21.58 (4), p < 0.001 * | 30.70 (4), | 17.77 (4), | |||||||||
| Up to primary education | 16 (4.3) | 13 (3.5) | 15 (4) | 5 (1.3) | 6 (1.6) | 33 (8.8) | 30 (8) | 7 (1.9) | 7 (1.9) | |||
| Intermediate | 120 (32.2) | 23 (6.2) | 40 (10.7) | 63 (16.9) | 24 (6.4) | 96 (25.7) | 126 (33.8) | 35 (9.4) | 22 (5.9) | |||
| Secondary and higher | 90 (24.1) | 40 (10.7) | 16 (4.3) | 58 (15.5) | 39 (10.5) | 49 (13.1) | 83 (22.3) | 19 (5.1) | 44 (11.8) | |||
* p < 0.05 considered statistically significant.
Assessment of caregiver practices in reviewing critical safety information on paracetamol labels.
| I Check the Directions for Use on the Label | χ2 (df) | p-Value | Warning on the Label | χ2 (df) | p-Value | AOR (95%CI) | p-Value | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes (%) | No (%) | Not Sure | Yes (%) | No (%) | |||||||
| Caregiver | 4.83 | 0.29 | 7.51 (2) | 0.023 * | |||||||
| Mother | 166 (44.5) | 12 (3.2) | 24 (6.4) | 115 (30.8) | 87 (23.2) | 1 | |||||
| Father | 99 (26.5) | 13 (3.5) | 21 (5.6) | 57 (15.3) | 76 (20.4) | 1.21 | 0.64 | ||||
| Relatives Nanny/ | 28 (7.5) | 2 (0.5) | 8 (2.1) | 16 (4.3) | 22 (5.9) | 1.88 | 0.10 | ||||
| Age (Years) | 3.17 (4) | 0.52 | 1.93 (2) | 0.38 | |||||||
| 18–30 | 61 (16.4) | 7 (1.9) | 14 (3.8) | 36 | 46 (12.3) | 0.73 | 0.40 | ||||
| 31–40 | 180 (48.3) | 15 (4) | 26 (7) | 114 (30.6) | 107 (28.7) | 0.99 | 0.98 | ||||
| Above 40 | 52 (13.9) | 5 (1.3) | 13 (3.5) | 38 (10.2) | 32 (8.6) | 1 | |||||
| Education | 15.98 a | 0.002 * | 61.60 (2) | 0.001 * | |||||||
| Up to primary education | 28 (7.5) | 10 (2.7) | 6 (1.6) | 11 (2.9) | 33 (8.8) | 0.11 | 0.001 * | ||||
| Intermediate | 144 (38.6) | 8 (2.1) | 31 (8.3) | 67 (18) | 116 (31.1) | 0.19 | 0.001 * | ||||
| Secondary and higher | 121 (32.4) | 9 (2.4) | 16 (4.3) | 110 (29.5) | 36 (9.7) | 1 | |||||
* p < 0.05 considered statistically significant. a Fisher exact test.
Assessing the caregiver practices of checking the expiry date.
| Check Expiry Date | χ2 (df) | p-Value | AOR (95%CI) | p-Value | ||
|---|---|---|---|---|---|---|
| Yes (%) | No (%) | |||||
| Caregiver | 3.37 (2) | 0.18 | ||||
| Mother | 155 (41.6) | 47 (12.6) | 1 | |||
| Father | 94 (25.2) | 39 (10.5) | 0.65 (0.22–1.84) | 0.41 | ||
| Relatives/Nanny | 32 (8.6) | 6 (1.6) | 0.71 (0.25–1.96) | 0.51 | ||
| Age (Years) | 1.90 (2) | 0.38 | ||||
| 18–30 | 58 (15.5) | 24 (6.4) | 0.69 (0.30–1.59) | 0.39 | ||
| 31–40 | 172 (46.1) | 49 (13.1) | 1.0 (0.48–2.07) | 0.98 | ||
| Above 40 | 51 (13.7) | 19 (5.1) | 1 | |||
| Education | 81.34 (2) | 0.001 * | ||||
| Up to primary education | 9 (2.4) | 35 (9.4) | 0.063 (0.027–0.14) | 0.001 * | ||
| Intermediate | 154 (41.3) | 29 (7.8) | 1.28 (0.71–2.29) | 0.40 | ||
| Secondary and higher | 118 (31.6) | 56 (15) | 1 | |||
* p < 0.05 considered statistically significant.
References
1. Mcgregor, A.C.; Moore, D. Infectious causes of fever of unknown origin. Clin. Med.; 2015; 15, pp. 285-287. [DOI: https://dx.doi.org/10.7861/clinmedicine.15-3-285] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26031981]
2. Tseng, F.-H.; Dietrich, M.L.; Coleman, J.; Thomas, P.E. Persistent fever in a teenager. Clin. Pediatr.; 2018; 57, pp. 1602-1605. [DOI: https://dx.doi.org/10.1177/0009922818790943] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30051728]
3. Schmidt, L.E. Age and paracetamol self-poisoning. Gut; 2005; 54, pp. 686-690. [DOI: https://dx.doi.org/10.1136/gut.2004.054619] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15831917]
4. Al Arifi, M.N.; Alwhaibi, A. Assessment of Saudi parents’ beliefs and behaviors towards management of child fever in Saudi Arabia-A cross-sectional study. Int. J. Environ. Res. Public Health; 2021; 18, 5217. [DOI: https://dx.doi.org/10.3390/ijerph18105217] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34068916]
5. Kamel, F.; Magadmi, R.; Abuouf, N.M.; Alqahtani, F.S.; Bamousa, A.A.; Alqutub, A.T.; Bagber, A.A.; Abdulgafor, A.H.; Alzahrani, F.; Alsafi, H. Knowledge, attitude, and practice of paracetamol and ibuprofen administration among caregivers of the pediatric age group in Jeddah. Cureus; 2021; 13, e12460. [DOI: https://dx.doi.org/10.7759/cureus.12460] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33654581]
6. Mirdad, O.A.; Esheba, G.E.; Mousa, A.H.; Nukaly, H.Y.; Alhindi, Y.Z.; Hariri, N.H.; Ayoub, N.; Alsanosi, S.M. Over-the-counter medication use among parents in Saudi Arabia. Int. J. Environ. Res. Public Health; 2023; 20, 1193. [DOI: https://dx.doi.org/10.3390/ijerph20021193] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36673949]
7. Abdulrahman, S.F.S.; Al-Anazi, N.; Abdulgader, E.; Alqahtani, T.; Alsukhayri, A.; Al-Shwail, A.; Aljifry, A.; Alsamaan, S.; Aboalshamat, K. Parents’ knowledge and management of children’s fevers in Saudi Arabia after the COVID-19 pandemic. Med. Sci.; 2022; 26, ms400e2456. [DOI: https://dx.doi.org/10.54905/disssi/v26i128/ms400e2456]
8. Hodson, A.; Woodland, L.; Smith, L.E.; Rubin, G.J. Parental perceptions of COVID-19-like illness in their children. Public Health; 2021; 194, pp. 29-32. [DOI: https://dx.doi.org/10.1016/j.puhe.2021.02.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33848816]
9. Enners, S.; Gradl, G.; Kieble, M.; Böhm, M.; Laufs, U.; Schulz, M. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiol. Drug Saf.; 2021; 30, pp. 1493-1503. [DOI: https://dx.doi.org/10.1002/pds.5324]
10. World Health Organization. WHO Updates Guidelines on Treatments for COVID-19. Available online: https://www.who.int/news/item/10-11-2023-who-updates-guidelines-on-treatments-for-covid-19 (accessed on 11 April 2024).
11. Ministry of Health. Saudi MoH Protocol for Patients Suspected of/Confirmed with COVID-19. Supportive Care and Antiviral Treatment of Suspected or Confirmed COVID-19 Infection. 2022; Available online: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf (accessed on 11 April 2024).
12. Leal, N.S.; Yu, Y.; Chen, Y.; Fedele, G.; Martins, L.M. Paracetamol is associated with a lower risk of COVID-19 infection and decreased ACE2 protein expression: A retrospective analysis. COVID; 2021; 1, pp. 218-229. [DOI: https://dx.doi.org/10.3390/covid1010018]
13. Mostafa, E.M.A.; Tawfik, A.M.; Abd-Elrahman, K.M. Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic. Toxicol. Rep.; 2022; 9, pp. 541-548. [DOI: https://dx.doi.org/10.1016/j.toxrep.2022.03.035] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35371923]
14. Sharma, C.V.; Mehta, V. Paracetamol: Mechanisms and updates. Contin. Educ. Anaesth. Crit. Care Pain; 2013; 14, pp. 153-158. [DOI: https://dx.doi.org/10.1093/bjaceaccp/mkt049]
15. Li, S.F.; Lacher, B.; Crain, E.F. Acetaminophen and ibuprofen dosing by parents. Pediatr. Emerg. Care; 2000; 16, pp. 394-397. [DOI: https://dx.doi.org/10.1097/00006565-200012000-00003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11138879]
16. Alomar, M.; Alenazi, F.; Alruwaili, N. Accuracy of acetaminophen dosing in children by caregivers in Saudi Arabia. Ann. Saudi Med.; 2011; 31, pp. 513-517. [DOI: https://dx.doi.org/10.4103/0256-4947.84630] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21911990]
17. Cairns, R.; Brown, J.A.; Wylie, C.E.; Dawson, A.H.; Isbister, G.K.; Buckley, N.A. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004–2017. Med. J. Aust.; 2019; 211, pp. 218-223. [DOI: https://dx.doi.org/10.5694/mja2.50296] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31389025]
18. Offor, S.J.; Amadi, C.N.; Chijioke-Nwauche, I.; Manautou, J.E.; Orisakwe, O.E. Potential deleterious effects of paracetamol dose regime used in Nigeria versus that of the United States of America. Toxicol. Rep.; 2022; 9, pp. 1035-1044. [DOI: https://dx.doi.org/10.1016/j.toxrep.2022.04.025] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36561959]
19. Durrieu, G.; Maupiler, M.; Rousseau, V.; Chebane, L.; Montastruc, F.; Bondon-Guitton, E.; Montastruc, J.L. Frequency and nature of adverse drug reactions due to non-prescription drugs in children: A retrospective analysis from the French pharmacovigilance database. Pediatr. Drugs; 2018; 20, pp. 81-87. [DOI: https://dx.doi.org/10.1007/s40272-017-0255-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28766184]
20. Sarrell, E.; Wielunsky, H. Antipyretic treatment in young children with fever: Acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Arch. Pediatr. Adolesc. Med.; 2006; 160, 197. [DOI: https://dx.doi.org/10.1001/archpedi.160.2.197] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16461878]
21. Al Hifzi, I.S.; Kumar, P.; Talol, W. Hospitalization due to acute poisoning in children—Tabuk experience. J. Fam. Community Med.; 1995; 2, pp. 27-30. [DOI: https://dx.doi.org/10.4103/2230-8229.98614]
22. Simkin, S.; Hawton, K.; Kapur, N.; Gunnell, D. What can be done to reduce mortality from paracetamol overdoses? A patient interview study. QJM; 2012; 105, pp. 41-51. [DOI: https://dx.doi.org/10.1093/qjmed/hcr135]
23. Gummin, D.D.; Mowry, J.B.; Beuhler, M.C.; Spyker, D.A.; Bronstein, A.C.; Rivers, L.J.; Pham, N.P.T.; Weber, J. 2020 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 38th Annual Report. Clin. Toxicol.; 2021; 59, pp. 1282-1501. [DOI: https://dx.doi.org/10.1080/15563650.2021.1989785]
24. Penna, A.; Buchanan, N. Paracetamol poisoning in children and hepatotoxicity. Br. J. Clin. Pharmacol.; 1991; 32, pp. 143-149. [DOI: https://dx.doi.org/10.1111/j.1365-2125.1991.tb03873.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1931463]
25. Al-Sheddi, A.; Kamel, S.; Almeshal, A.S.; Assiri, A.M. Distribution of Primary Healthcare Centers between 2017 and 2021 across Saudi Arabia. Cureus; 2023; 15, e41932. [DOI: https://dx.doi.org/10.7759/cureus.41932] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37583734]
26. Chong, C.P.; Tan, S.F.; Chooi, W.-T. Exploring consumers’ perceptions and knowledge of acetaminophen (paracetamol): A cross-sectional study from Penang, Malaysia. Int. J. Pharma Sci. Res. IJPSR; 2020; 11, pp. 52-57.
27. Daifallah, A.; Jabr, R.; Al-Tawil, F.; Elkourdi, M.; Salman, Z.; Koni, A.; Samara, A.; Al-Jabi, S.W.; Zyoud, S.H. An assessment of parents’ knowledge and awareness regarding paracetamol use in children: A cross-sectional study from Palestine. BMC Public Health; 2021; 21, 380. [DOI: https://dx.doi.org/10.1186/s12889-021-10432-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33602192]
28. Obu, H.A.; Chinawa, J.M.; Ubesie, A.C.; Eke, C.B.; Ndu, I.K. Paracetamol use (and/or misuse) in children in Enugu, South-East, Nigeria. BMC Pediatr.; 2012; 12, 103. [DOI: https://dx.doi.org/10.1186/1471-2431-12-103] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22812400]
29. Tan, E.; Braithwaite, I.; McKinlay, C.J.D.; Dalziel, S.R. Comparison of acetaminophen (Paracetamol) with ibuprofen for treatment of fever or pain in children younger than 2 years: A systematic review and meta-analysis. JAMA Netw. Open; 2020; 3, e2022398. [DOI: https://dx.doi.org/10.1001/jamanetworkopen.2020.22398] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33125495]
30. Saljoughian, M. Acetaminophen Intoxication: A Critical-Care Emergency. 2016; Available online: https://www.uspharmacist.com/article/acetaminophen-intoxication-a-criticalcare-emergency (accessed on 12 April 2024).
31. De Bont, E.; Bohnen, J.; Verhoeven, R.; Dinant, G.J.; Cals, J.W.L. Childhood fever: Parental paracetamol administration after consulting out-of-hours general practice. Eur. J. Gen. Pract.; 2020; 26, pp. 21-25. [DOI: https://dx.doi.org/10.1080/13814788.2019.1676415] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31617769]
32. Lubrano, R.; Paoli, S.; Bonci, M.; Di Ruzza, L.; Cecchetti, C.; Falsaperla, R.; Pavone, P.; Matin, N.; Vitaliti, G.; Gentile, I. Acetaminophen administration in pediatric age: An observational prospective cross-sectional study. Ital. J. Pediatr.; 2016; 42, 20. [DOI: https://dx.doi.org/10.1186/s13052-016-0219-x]
33. Ogunyinka, I.A.; Oshikoya, K.A.; Yusuff, K.B.; Tahir, Y.; Yahaya, M.; Adeniye, S.B.; Oforkansi, I.E. Determinants of caregiver’s knowledge and practices regarding childhood fever management in a developing setting: A multi-centre cross-sectional assessment. Front. Pediatr.; 2023; 22, 1119067. [DOI: https://dx.doi.org/10.3389/fped.2023.1119067]
34. Mattiuzzi, C.; Lippi, G. How much has COVID-19 contributed to increase the worldwide consumption of paracetamol and ibuprofen? Evidence from an infodemiological analysis. Hosp. Pharm.; 2023; 58, pp. 7-8. [DOI: https://dx.doi.org/10.1177/00185787221125721] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36644739]
35. Yeoh, E.T.; Goh, A.W.L.; Chong, C.P. Evaluation of the practices of using paracetamol among parents in treating their children in Penang, Malaysia. J. App Pharm. Sci.; 2022; 12, pp. 120-130.
36. Kloeden, B.; Tham, D.; Oakley, E.; Cheek, J. Community use of paracetamol and ibuprofen in children with fever. J. Paediatr. Child Health; 2021; 57, pp. 1640-1644. [DOI: https://dx.doi.org/10.1111/jpc.15580] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34036655]
37. Zempsky, W.T.; Bhagat, P.K.; Siddiqui, K. Practical challenges-Use of paracetamol in children and youth who are overweight or obese: A narrative review. Paediatr. Drugs; 2020; 22, pp. 525-534. [DOI: https://dx.doi.org/10.1007/s40272-020-00417-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32918268]
38. Mullan, J.; Burns, P.; Sargeant, D. Caregivers’ knowledge about children’s paracetamol. J. Pharm. Pract. Res.; 2018; 48, pp. 454-458. [DOI: https://dx.doi.org/10.1002/jppr.1431]
39. Tobaiqy, M.; Maclure, K.; Radwi, M.; Almalki, A.M.; Alhasan, A.H.; Tannoury, M.; Attieh, Z. Parental Experience of Potential Adverse Drug Reactions Related to Their Oral Administration of Antipyretic Analgesic Medicines in Children in Saudi Arabia. Curr. Ther. Res.; 2020; 92, 100592. [DOI: https://dx.doi.org/10.1016/j.curtheres.2020.100592] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32714474]
40. Tariq, M.; Din, F.U. Poor knowledge of university students regarding paracetamol; a wakeup call for public healthcare practitioners. Cogent Med.; 2017; 4, 1320848. [DOI: https://dx.doi.org/10.1080/2331205X.2017.1320848]
41. Umuhoza, C.; Karambizi, A.C.; Tuyisenge, L.; Cartledge, P. Caregiver delay in seeking healthcare during the acute phase of pediatric illness, Kigali, Rwanda. Pan Afr. Med. J.; 2018; 30, 160. [DOI: https://dx.doi.org/10.11604/pamj.2018.30.160.15286] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30455789]
42. Ferner, R.E. Management of paracetamol poisoning. BMJ; 2011; 342, d2218. [DOI: https://dx.doi.org/10.1136/bmj.d2218]
43. Bolesta, S.; Haber, S.L. Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. Ann. Pharmacother.; 2002; 36, pp. 331-333. [DOI: https://dx.doi.org/10.1345/aph.1A035]
44. Caparrotta, T.M.; Antoine, D.J.; Dear, J.W. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. Eur. J. Clin. Pharmacol.; 2018; 74, pp. 147-160. [DOI: https://dx.doi.org/10.1007/s00228-017-2356-6] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29067481]
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Banji, Otilia J F 3 1 Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia;
2 Department of Pharmacology & Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia
3 Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia